The global dental biomaterials market size was USD 9.02 billion in 2023, calculated at USD 9.62 billion in 2024 and is expected to reach around USD 18.4 billion by 2034, expanding at a CAGR of 6.7% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dental Biomaterials Market, by Type, 2024-2034
8.1.1. Metallic Biomaterials
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Ceramic Biomaterials
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Polymeric Biomaterials
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Metal-Ceramic Biomaterials
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Natural Biomaterials
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Composites Biomaterials
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Dental Biomaterials Market, by Application, 2024-2034
9.1.1. Implantology
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Orthodontics
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Prosthodontics
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Dental Biomaterials Market, by End Use Type, 2024-2034
10.1.1. Dental Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Dental Laboratories
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Dental Academics and Research Institutes
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Dental Product Manufacturers
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Dental Biomaterials Market, by Bone Graft Material Type, 2024-2034
11.1.1. Allograft
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Xenograft
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Synthetic
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.1.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.2.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.3.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.4.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by End Use Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2021-2034)
13.1. 3M Company
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bego Medical GmbH
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Carpenter Technology Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Danaher Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Datum Dental Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GC Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Henry Schein Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. IvoclarVivadent AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Keystone Dental Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medtronic PLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample